Latest Period
Q1 2026
Security Snapshot
AVANOS MEDICAL, INC. - Common Stock (AVNS) Institutional Ownership
CUSIP: 05350V106
13F Institutional Holders and Ownership History from Q1 2016 to Q2 2026
Institutions Reporting
249
Shares (Excl. Options)
44,861,219
Price
$14.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- AVNS on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 44,861,219
- Total 13F value
- $628,224,699
- Portfolio coverage rank
- 0%
- Share change
- -519,363
- Value change
- -$3,011,069
- Number of holders
- 249
- Shares outstanding
- 46,883,900
- SEC-reported price per share
- $24.88
- Insider filing price
- $24.88
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AVNS - AVANOS MEDICAL, INC. - Common Stock is tracked under CUSIP 05350V106.
- 249 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 249 to 117 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $628,224,699 to $319,402,636.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 249 institutions filings for Q1 2026.
Security key
05350V106
Latest holder period
Q1 2026
13F holders
249
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
AVNS full holder history
AVANOS MEDICAL, INC. SEC filings
AVANOS MEDICAL, INC. company facts
AVANOS MEDICAL, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05350V106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
AVNS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $84,305,460 | 6,826,353 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $58,323,572 | 2,344,195 | Vanguard Capital Management | 30 Jun 2026 | |||
| DIMENSIONAL FUND ADVISORS LP | 4.6% | -10% | $24,230,152 | -$2,191,104 | 2,157,531 | -8.3% | Dimensional Fund Advisors LP | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC | 4.3% | -37% | $29,060,000 | -$17,436,000 | 2,000,000 | -38% | Armistice Capital, LLC | 31 Mar 2026 |
| T. Rowe Price Investment Management, Inc. | 3.7% | -65% | $24,752,000 | -$52,704,175 | 1,703,510 | -68% | T. Rowe Price Investment Management, Inc. | 30 Apr 2026 |
As of 31 Mar 2026, 249 institutional investors reported holding 44,861,219 shares of AVANOS MEDICAL, INC. - Common Stock (AVNS). This represents 96% of the company’s total 46,883,900 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
78%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | 6,843,733 | +1.4% | 0% | $95,880,704 |
| T. Rowe Price Investment Management, Inc. | 11% | 5,330,776 | +19% | 0.05% | $74,685,000 |
| BROWN ADVISORY INC | 4.8% | 2,231,198 | +15% | 0.05% | $31,259,092 |
| DIMENSIONAL FUND ADVISORS LP | 4.4% | 2,052,356 | -4.9% | 0.01% | $28,752,636 |
| ARMISTICE CAPITAL, LLC | 4.3% | 2,000,000 | -38% | 0.93% | $28,020,000 |
| STATE STREET CORP | 4.2% | 1,972,523 | +0.91% | 0% | $27,635,047 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 1,971,965 | 0% | 0% | $27,627,230 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.6% | 1,239,295 | 0% | 0% | $17,362,523 |
| ACADIAN ASSET MANAGEMENT LLC | 2.6% | 1,214,930 | +27% | 0.02% | $17,013,000 |
| Thrivent Financial for Lutherans | 2.5% | 1,187,956 | +460% | 0.03% | $16,644,000 |
| BOONE CAPITAL MANAGEMENT LLC | 2.5% | 1,184,909 | 5.1% | $16,600,575 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,094,235 | +0.9% | 0% | $15,331,791 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.3% | 1,058,066 | +1.7% | 0% | $14,823,505 |
| CLARK ESTATES INC/NY | 1.8% | 845,000 | -4.9% | 2.8% | $11,838,450 |
| MORGAN STANLEY | 1.8% | 827,662 | -24% | 0% | $11,595,558 |
| AQR CAPITAL MANAGEMENT LLC | 1.5% | 691,250 | -5% | 0% | $9,608,376 |
| D. E. Shaw & Co., Inc. | 1.4% | 671,413 | -45% | 0.01% | $9,406,496 |
| AMERIPRISE FINANCIAL INC | 1.2% | 584,277 | +0.29% | 0% | $8,185,727 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | 1.2% | 573,940 | +13% | 0.05% | $8,040,899 |
| ROYCE & ASSOCIATES LP | 1.1% | 513,703 | +746% | 0.07% | $7,196,979 |
| NORTHERN TRUST CORP | 1% | 489,221 | +3.4% | 0% | $6,853,987 |
| GOLDMAN SACHS GROUP INC | 1% | 480,886 | +6.5% | 0% | $6,737,212 |
| CITADEL ADVISORS LLC | 1% | 475,196 | -0.72% | 0% | $6,657,496 |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 0.93% | 437,085 | +62% | 0.35% | $6,123,561 |
| ExodusPoint Capital Management, LP | 0.9% | 421,504 | -28% | 0.06% | $5,905,271 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
42
Latest
Q1 2026
Rows shown
1-25 of 42
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 12,837,760 | $319,402,636 | +$37,023,637 | $24.88 | 117 |
| 2026 Q1 | 44,861,219 | $628,224,699 | -$3,011,069 | $14.01 | 249 |
| 2025 Q4 | 45,384,712 | $509,776,376 | +$5,467,835 | $11.23 | 272 |
| 2025 Q3 | 44,915,629 | $519,212,625 | -$456,743 | $11.56 | 269 |
| 2025 Q2 | 44,711,937 | $547,287,477 | +$14,185,298 | $12.24 | 279 |
| 2025 Q1 | 43,396,946 | $623,274,490 | -$6,741,914 | $14.33 | 275 |
| 2024 Q4 | 43,159,764 | $687,053,030 | -$348,352 | $15.92 | 253 |
| 2024 Q3 | 42,887,071 | $1,030,142,636 | +$14,845,110 | $24.03 | 257 |
| 2024 Q2 | 42,331,138 | $843,184,184 | -$19,844,468 | $19.92 | 254 |
| 2024 Q1 | 43,394,488 | $863,829,555 | -$12,610,070 | $19.91 | 255 |
| 2023 Q4 | 43,936,227 | $986,177,329 | +$6,301,621 | $22.43 | 261 |
| 2023 Q3 | 43,653,986 | $883,886,301 | -$24,810,694 | $20.22 | 251 |
| 2023 Q2 | 44,367,274 | $1,134,245,375 | +$6,577,133 | $25.56 | 267 |
| 2023 Q1 | 43,807,927 | $1,302,667,520 | +$18,327,231 | $29.74 | 278 |
| 2022 Q4 | 43,474,984 | $1,176,504,936 | +$5,615,427 | $27.06 | 274 |
| 2022 Q3 | 43,372,951 | $944,662,406 | -$2,543,596 | $21.78 | 218 |
| 2022 Q2 | 43,323,037 | $1,184,314,252 | -$13,685,481 | $27.34 | 227 |
| 2022 Q1 | 43,970,678 | $1,472,010,622 | +$2,331,652 | $33.50 | 252 |
| 2021 Q4 | 43,852,763 | $1,519,830,657 | +$2,873,575 | $34.67 | 251 |
| 2021 Q3 | 43,701,330 | $1,363,473,910 | -$25,618,497 | $31.20 | 229 |
| 2021 Q2 | 44,393,122 | $1,614,401,834 | +$1,417,948 | $36.37 | 239 |
| 2021 Q1 | 44,092,800 | $1,928,597,642 | -$45,329,737 | $43.74 | 251 |
| 2020 Q4 | 45,157,960 | $2,071,803,289 | -$25,305,709 | $45.88 | 240 |
| 2020 Q3 | 45,956,879 | $1,526,673,060 | -$9,601,150 | $33.22 | 230 |
| 2020 Q2 | 46,293,558 | $1,360,488,473 | +$21,246,989 | $29.39 | 233 |